Loss and gain of function of MeCP2 lead to Rett syndrome (RTT) and MECP2 duplication syndrome (MDS), respectively, which are two severe neurological disorders characterized by intellectual disability, autism, and developmental regression [1, 2]. This evidence concerns the gene MECP2 and myelodysplastic syndrome.